Blocking humanitarian organizations from accessing a medical breakthrough puts people who are vulnerable across the world in danger. Doctors Without Borders/Médecins Sans Frontières (MSF) sent an open letter to the U.S. pharmaceutical corporation Gilead Sciences on March 30, calling on the company to immediately sell to MSF, lenacapavir, an HIV medicine that is one of the most important advances in HIV prevention in decades. About 1.3 […]
Read More… from MSF wants to buy groundbreaking HIV prevention drug. Why won’t Gilead sell?